Characterization of beta papillomavirus E4 expression in tumours from Epidermodysplasia Verruciformis patients and in experimental models

Virology

Volumn 423, Issue 2, 2012, Pages 195-204

  Borgogna, Cinzia ^a,b   Zavattaro, Elisa ^a   De Andrea, Marco ^a,c   Griffin, Heather M ^b   Dell'Oste, Valentina ^c   Azzimonti, Barbara ^a   Landini, Manuela M ^a   Peh, Woei Ling ^b   Pfister, Herbert ^d   Doorbar, John ^b   Landolfo, Santo ^c   Gariglio, Marisa ^a  

^a Amedeo Avogadro University   (Italy)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^c UNIVERSITY OF TURIN   (Italy)

^d UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Beta papillomavirus; E4; Epidermodysplasia Verruciformis; Skin cancer

Indexed keywords

CYCLINE; VIRUS DNA; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETAPAPILLOMAVIRUS; CELL CULTURE; CELL DIFFERENTIATION; CYTOPLASM; DISEASE SEVERITY; EPIDERMODYSPLASIA VERRUCIFORMIS; EXPERIMENTAL MODEL; GENE AMPLIFICATION; HISTOCHEMISTRY; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CANCER; SKIN CARCINOGENESIS; SKIN EPITHELIUM; TRANSGENIC MOUSE; VIROGENESIS; VIRUS GENOME; VIRUS LOAD; VIRUS REPLICATION; VIRUS TYPING;

ANIMALS; BETAPAPILLOMAVIRUS; CELL LINE; DISEASE MODELS, ANIMAL; EPIDERMODYSPLASIA VERRUCIFORMIS; HUMANS; KERATINOCYTES; MICE; MICE, TRANSGENIC; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS;

HUMAN PAPILLOMAVIRUS; MUS MUSCULUS; PAPILLOMAVIRIDAE;

EID: 84855798262     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.11.029     Document Type: Article

References (45)

1. Akgul B., Garcia-Escudero R., Ghali L., Pfister H.J., Fuchs P.G., Navsaria H., Storey A. The E7 protein of cutaneous human papillomavirus type 8 causes invasion of human keratinocytes into the dermis in organotypic cultures of skin. Cancer Res. 2005, 65:2216-2223.
2. Akgul B., Cooke J.C., Storey A. HPV-associated skin disease. J. Pathol. 2006, 208:165-175.
3. Antonsson A., Forslund O., Ekberg H., Sterner G., Hansson B.G. The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a commensalic nature of these viruses. J. Virol. 2000, 74:11636-11641.
4. Azzimonti B., Dell'oste V., Borgogna C., Mondini M., Gugliesi F., De Andrea M., Chiorino G., Scatolini M., Ghimenti C., Landolfo S., Gariglio M. The epithelial-mesenchymal transition induced by keratinocyte growth conditions is overcome by E6 and E7 from HPV16, but not HPV8 and HPV38: characterization of global transcription profiles. Virology 2009, 388:260-269.
5. Bernard H.U., Burk R.D., Chen Z., van Doorslaer K., zur Hausen H., de Villiers E.M. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 2010, 401:70-79.
6. Bravo I.G., de Sanjose S., Gottschling M. The clinical importance of understanding the evolution of papillomaviruses. Trends Microbiol. 2010, 18:432-438.
7. Davy C.E., Ayub M., Jackson D.J., Das P., McIntosh P., Doorbar J. HPV16 E1-E4 protein is phosphorylated by Cdk2/cyclin A and relocalizes this complex to the cytoplasm. Virology 2006, 349:230-244.
8. De Andrea M., Ritta M., Landini M.M., Borgogna C., Mondini M., Kern F., Ehrenreiter K., Baccarini M., Marcuzzi G.P., Smola S., Pfister H., Landolfo S., Gariglio M. Keratinocyte-specific stat3 heterozygosity impairs development of skin tumors in human papillomavirus 8 transgenic mice. Cancer Res. 2010, 70:7938-7948.
9. de Koning M., Quint W., Struijk L., Kleter B., Wanningen P., van Doorn L.J., Weissenborn S.J., Feltkamp M., ter Schegget J. Evaluation of a novel highly sensitive, broad-spectrum PCR-reverse hybridization assay for detection and identification of beta-papillomavirus DNA. J. Clin. Microbiol. 2006, 44:1792-1800.
10. Dell'Oste V., Azzimonti B., De Andrea M., Mondini M., Zavattaro E., Leigheb G., Weissenborn S.J., Pfister H., Michael K.M., Waterboer T., Pawlita M., Amantea A., Landolfo S., Gariglio M. High beta-HPV DNA loads and strong seroreactivity are present in epidermodysplasia verruciformis. J. Invest. Dermatol. 2009, 129:1026-1034.
11. Doorbar J. The papillomavirus life cycle. J. Clin. Virol. 2005, 32(Suppl. 1):S7-S15.
12. Doorbar J. Papillomavirus life cycle organization and biomarker selection. Dis. Markers 2007, 23:297-313.
13. Doorbar J., Campbell D., Grand R.J., Gallimore P.H. Identification of the human papilloma virus-1a E4 gene products. EMBO J. 1986, 5:355-362.
14. Doorbar J., Evans H.S., Coneron I., Crawford L.V., Gallimore P.H. Analysis of HPV-1 E4 gene expression using epitope-defined antibodies. EMBO J. 1988, 7:825-833.
15. Doorbar J., Ely S., Sterling J., McLean C., Crawford L. Specific interaction between HPV-16 E1-E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network. Nature 1991, 352:824-827.
16. Doorbar J., Foo C., Coleman N., Medcalf L., Hartley O., Prospero T., Napthine S., Sterling J., Winter G., Griffin H. Characterization of events during the late stages of HPV16 infection in vivo using high-affinity synthetic Fabs to E4. Virology 1997, 238:40-52.
17. Feltkamp M.C., de Koning M.N., Bavinck J.N., Ter Schegget J. Betapapillomaviruses: innocent bystanders or causes of skin cancer. J. Clin. Virol. 2008, 43:353-360.
18. Galloway D.A. Human papillomaviruses: a growing field. Genes Dev. 2009, 23:138-142.
19. Jablonska S., Majewski S. Epidermodysplasia verruciformis: immunological and clinical aspects. Curr. Top. Microbiol. Immunol. 1994, 186:157-175.
20. Karlen S., Beard P. Identification and characterization of novel promoters in the genome of human papillomavirus type 18. J. Virol. 1993, 67:4296-4306.
21. Karlen S., Offord E.A., Beard P. Functional promoters in the genome of human papillomavirus type 6b. J. Gen. Virol. 1996, 77(Pt 1):11-16.
22. Landini M., Zavattaro E., Borgogna C., Azzimonti B., De Andrea M., Colombo E., Marenco F., Amantea A., Landolfo S., Gariglio M. Lack of EVER2 protein in two Epidermodysplasia Verruciformis patients with skin cancer presenting novel homozygous genetic deletions in the EVER2 gene. J. Invest. Dermatol 2011, 10.1038/jid.2011.399.
23. Lazarczyk M., Pons C., Mendoza J.A., Cassonnet P., Jacob Y., Favre M. Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses. J. Exp. Med. 2008, 205:35-42.
24. Lazarczyk M., Cassonnet P., Pons C., Jacob Y., Favre M. The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections. Microbiol. Mol. Biol. Rev. 2009, 73:348-370.
25. Middleton K., Peh W., Southern S., Griffin H., Sotlar K., Nakahara T., El-Sherif A., Morris L., Seth R., Hibma M., Jenkins D., Lambert P., Coleman N., Doorbar J. Organization of human papillomavirus productive cycle during neoplastic progression provides a basis for selection of diagnostic markers. J. Virol. 2003, 77:10186-10201.
26. Nakahara T., Peh W.L., Doorbar J., Lee D., Lambert P.F. Human papillomavirus type 16 E1circumflexE4 contributes to multiple facets of the papillomavirus life cycle. J. Virol. 2005, 79:13150-13165.
27. Nicholls P.K., Klaunberg B.A., Moore R.A., Santos E.B., Parry N.R., Gough G.W., Stanley M.A. Naturally occurring, nonregressing canine oral papillomavirus infection: host immunity, virus characterization, and experimental infection. Virology 1999, 265:365-374.
28. Nicholls P.K., Doorbar J., Moore R.A., Peh W., Anderson D.M., Stanley M.A. Detection of viral DNA and E4 protein in basal keratinocytes of experimental canine oral papillomavirus lesions. Virology 2001, 284:82-98.
29. Nindl I., Gottschling M., Stockfleth E. Human papillomaviruses and non-melanoma skin cancer: basic virology and clinical manifestations. Dis. Markers 2007, 23:247-259.
30. Ojeh N.O., Frame J.D., Navsaria H.A. In vitro characterization of an artificial dermal scaffold. Tissue Eng. 2001, 7:457-472.
31. Orth G. Genetics of epidermodysplasia verruciformis: insights into host defense against papillomaviruses. Semin. Immunol. 2006, 18:362-374.
32. Peh W.L., Doorbar J. Detection of papillomavirus proteins and DNA in paraffin-embedded tissue sections. Methods Mol. Med. 2005, 119:49-59.
33. Peh W.L., Middleton K., Christensen N., Nicholls P., Egawa K., Sotlar K., Brandsma J., Percival A., Lewis J., Liu W.J., Doorbar J. Life cycle heterogeneity in animal models of human papillomavirus-associated disease. J. Virol. 2002, 76:10401-10416.
34. Peh W.L., Brandsma J.L., Christensen N.D., Cladel N.M., Wu X., Doorbar J. The viral E4 protein is required for the completion of the cottontail rabbit papillomavirus productive cycle in vivo. J. Virol. 2004, 78:2142-2151.
35. Pfister H. Chapter 8: human papillomavirus and skin cancer. J. Natl. Cancer Inst. Monogr. 2003, 31:52-56.
36. Purdie K.J., Surentheran T., Sterling J.C., Bell L., McGregor J.M., Proby C.M., Harwood C.A., Breuer J. Human papillomavirus gene expression in cutaneous squamous cell carcinomas from immunosuppressed and immunocompetent individuals. J. Invest. Dermatol. 2005, 125:98-107.
37. Ramoz N., Rueda L.A., Bouadjar B., Montoya L.S., Orth G., Favre M. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat. Genet. 2002, 32:579-581.
38. Roberts S. The E4 protein - a late starter. Papillomavirus research. From Natural History To Vaccines and Beyond 2006, 83-96. Caister Academic Press, Norwich. S. Campo (Ed.).
39. Roberts S., Ashmole I., Johnson G.D., Kreider J.W., Gallimore P.H. Cutaneous and mucosal human papillomavirus E4 proteins form intermediate filament-like structures in epithelial cells. Virology 1993, 197:176-187.
40. Roberts S., Ashmole I., Gibson L.J., Rookes S.M., Barton G.J., Gallimore P.H. Mutational analysis of human papillomavirus E4 proteins: identification of structural features important in the formation of cytoplasmic E4/cytokeratin networks in epithelial cells. J. Virol. 1994, 68:6432-6445.
41. Schaper I.D., Marcuzzi G.P., Weissenborn S.J., Kasper H.U., Dries V., Smyth N., Fuchs P., Pfister H. Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8. Cancer Res. 2005, 65:1394-1400.
42. Skin Cancer After Organ Transplantation 2009, 502. The SCOPE Collaborative Group, Springer Press, Berlin.
43. Wang H.K., Duffy A.A., Broker T.R., Chow L.T. Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes. Genes Dev. 2009, 23:181-194.
44. Zhao W., Chow L.T., Broker T.R. Transcription activities of human papillomavirus type 11 E6 promoter-proximal elements in raft and submerged cultures of foreskin keratinocytes. J. Virol. 1997, 71:8832-8840.
45. zur Hausen H. Papillomaviruses in the causation of human cancers - a brief historical account. Virology 2009, 384:260-265.